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Preadipocyte factor 1 (Pref-1, also called Dlk1/FA1) is a molecular gatekeeper of adi-
pogenesis which acts by maintaining the preadipocyte state and preventing adipocyte
differentiation. Pref-1 is made as an epidermal growth factor-like repeat containing trans-
membrane protein, and is cleaved byTNFα-converting enzyme (TACE) to generate a soluble
form, which acts as an autocrine/paracrine factor. Pref-1 upregulates Sox9 expression by
activating the ERK/MAPK pathway and the Pref-1 interaction with fibronectin is required
for inhibition of adipogenesis. Pref-1 also prevents brown adipocyte differentiation and
its thermogenic function. Here, we highlight the recent evidence for the role of Pref-1 in
adipogenesis.
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Obesity, characterized by an increase in white adipose tissue
(WAT) mass, has become a major health problem on an epidemic
scale and is associated with increased risk of various diseases, such
as cardiovascular diseases and diabetes. Throughout the lifespan,
adipose tissue not only expands through hypertrophy of existing
adipocytes, but also through hyperplasia of preadipocytes differ-
entiating into adipocytes. Various factors that affect differentiation
have been identified. However, despite major advances in adipose
biology, the underlying processes and mechanisms for adipose tis-
sue development and its expansion are not fully understood. In
addition, with the recent evidence of the presence of functional
brown adipose tissue (BAT) in adults, implicating its potential
as a therapeutic target for obesity, attention has been focused on
understanding the development of BAT, which dissipates energy,
in contrast to WAT that serves as the major energy storage organ.
ADIPOCYTE DIFFERENTIATION
Adipose tissue contains heterogeneous cell types. In addition
to lipid filled adipocytes, adipose tissue contains the so-called
stromal vascular fraction (SVF) composed of preadipocytes,
macrophages, endothelial cells, and other fibroblast-like cells.
Primary preadipocytes and preadipocyte cell lines, such as 3T3-
L1 and 3T3-FT442A cells, undergo differentiation in the pres-
ence of adipogenic media containing dexamethasone (DEX),
isobutylmethylxanthine (IBMX), and insulin and the differenti-
ation process has been extensively studied at the transcriptional
level. Intricate coordination of various transcription factors is
required for differentiation. CCAAT/enhancer binding protein β
(C/EBPβ) and C/EBPδ are induced early during differentiation and
activate peroxisome proliferator-activated receptorγ (PPARγ) and
C/EBPα. PPARγ, is necessary and sufficient to promote adipocyte
differentiation, and treatment with PPARγ agonists, thiazolidine-
diones, can promote differentiation in vitro (1). Since the discovery
of PPARγ, many additional transcription factors that play a role
in adipocyte differentiation have been identified and have been
extensively reviewed elsewhere (2–7). Recent research has been
devoted to identifying unique markers of preadipocytes or adipose
progenitors. In this regard, ZFP423 has been reported to be critical
for the preadipocyte commitment process (8). And, PRDM16 has
been identified as a major player in the differentiation of brown
adipocytes (9).
Not only does adipose tissue play a critical role in energy metab-
olism by being the major energy storage organ, it also secretes
and responds to a variety of molecules involved in energy home-
ostasis, immunity, and vascular function. The role of leptin and
adiponectin, two cytokines that are secreted by adipocytes and
regulate energy homeostasis, have been well described elsewhere
(10, 11). Inflammatory cytokines such as TNF-α and IL-6 are also
secreted from adipocytes (12). TNFα may help recruit mesenchy-
mal precursors from other organs to the adipose tissue, which
may then undergo differentiation to form new adipocytes (13). We
originally identified Preadipocyte factor-1 [Pref-1; also called Dlk1
(Delta-like protein-1), fetal antigen-1 (FA1)] as a preadipocyte fac-
tor that prevents adipocyte differentiation and Pref-1 expression
is decreased during differentiation to allow adipogenesis (14–
16). While many of the adipose related cytokines are secreted
from adipocytes, Pref-1 is produced by preadipocytes and acts
in an autocrine/paracrine fashion. This review highlights recent
advances in the knowledge of the role of Pref-1 in the regulation
of adipocyte differentiation and its signaling mechanism, as well
as its effects on BAT.
PREF-1 STRUCTURE AND SIGNALING
Pref-1 is synthesized as a transmembrane protein that contains
six EGF-like repeats at the extracellular domain (17, 18). These
repeats maintain the conserved spacing to form three disulfide
bonds from six cysteine residues (19). Upon proteolytic cleavage
by TNF-α converting enzyme (TACE), multiple soluble forms of
Pref-1 are generated and the larger 50 kDa form is biologically
active. Pref-1 cleavage by TACE can be inhibited by GM6001, a
broad metalloproteinase inhibitor, indicating that Pref-1 cleav-
age is dependent on metalloproteinase activity, and this activity
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is enhanced by phorbol ester treatment, showing that Protein
Kinase C may regulate Pref-1 cleavage. Though DEX treatment
down-regulates Pref-1 expression, regulation of Pref-1 activity
may also occur at the proteolytic cleavage step (20).
We demonstrated that Pref-1 rapidly induces Sox9 expression
through activation of the MEK/ERK pathway (21). Thus, Sox9
constitutive overexpression can inhibit adipocyte differentiation.
Downregulation of Pref-1 during differentiation coincides with
increased C/EBPβ and C/EBPδ, which occurs prior to C/EBPα and
PPARγ induction. Induction of Sox9 by Pref-1 during adipocyte
differentiation is at the very early stage, and Sox9 acts to main-
tain cells in a preadipocyte state by suppressing transcription of
C/EBPβ and C/EBPδ by directly binding to their promoter regions.
We also found that Pref-1 not only inhibits adipogenesis, but pro-
motes chondrogenic commitment (21). In this regard, Sox9 has
been known to function in chondrogenesis, and Sox9 ablation
in mice results in the prevention of cartilage formation. We have
observed that, like Sox9, ablation of Pref-1 causes malformation of
skeletons in mice. Pref-1 causes inhibition of osteoblast differenti-
ation, also via its induction of Sox9 that in turn prevents expression
of an osteogenic transcription factor, Runx2. These similar in vitro
and in vivo effects observed further demonstrate that physiological
effects of Pref-1 are mediated via its induction of Sox9 expression.
The mechanistic details of the Pref-1 signaling pathway have
been recently uncovered. Although it has been proposed that Pref-
1 may function in the Notch signaling pathway due to the presence
of EGF repeats (22,23),Pref-1 lacks the Delta:Serrate:Lin-12 (DSL)
domain that is required to mediate activation of Notch. Further-
more, we found that there is no direct interaction between Pref-1
and Notch, nor were there any changes in the expression of a
downstream target of Notch, Hes-1, by Pref-1. Though the putative
Pref-1 receptor is yet to be identified, we found that Pref-1 interacts
with fibronectin (24). The Pref-1 interaction with the C-terminal
domain of fibronectin is necessary for the Pref-1 inhibition of
adipocyte differentiation. Several growth factors are known to
bind various regions of fibronectin for modulation of growth fac-
tor function. Furthermore, fibronectin was shown previously to
prevent adipocyte differentiation (25, 26). We found that knock-
down of fibronectin or addition of Pref-1 interacting domains of
fibronectin prevent the Pref-1 mediated activation of MEK/ERK
and Sox9 induction, resulting in enhancement of adipocyte dif-
ferentiation. Furthermore, knockdown of the α5 of the major
integrin in preadipocytes, α5β1, or treatment with RGD pep-
tide which blocks the fibronectin interaction, prevent the Pref-1
inhibitory action on adipocyte differentiation. Pref-1-fibronectin-
integrin interaction activates the FAK/Src complex and Rho-like
GTPases, which can then activate the ERK/MAPK pathway (27).
Overall, Pref-1 directly binds fibronectin and activates integrin
signaling through ERK/MAPK to inhibit adipocyte differentiation
(24) (Figure 1).
ROLE OF PREF-1 DURING ADIPOGENESIS
As described above, Pref-1 was originally identified as an inhibitor
of adipocyte differentiation and its effect on WAT development
has been well documented in vitro and in vivo. Overexpression
of Pref-1 in 3T3-L1 preadipocytes drastically lowers the degree
of adipocyte differentiation, and knocking down Pref-1 greatly
increases differentiation (14, 28). Furthermore, we have generated
Pref-1 null mice as well as transgenic mice overexpressing Pref-
1 (29–31). Pref-1 null mice have increased adiposity and also
higher mRNA levels of adipocyte markers. On the other hand,mice
overexpressing Pref-1 have decreased adipose mass and decreased
adipocyte marker expression. As observed in lipodystrophy mod-
els, these mice also have hypertriglyceridemia, decreased glucose
tolerance, and lower insulin sensitivity (31). We can conclude that
Pref-1 clearly affects adipogenesis.
The role of Pref-1 in BAT has not been well explored. As in
WAT, however, it is known that Pref-1 is downregulated during
BAT development, being present at a very high level in fetuses but
decreasing to an undetectable level several weeks after birth (32).
Though BAT appeared to be normal prior to birth, Pref-1 ablated
mice show altered BAT morphology after birth, with potential
thermogenic over-activation, indicated by the induction of ther-
mogenic markers and enhanced lipid mobilization. Conversely,
in lipodystrophy mouse models, Pref-1 is expressed at a higher
level in BAT, which is associated with loss of thermogenesis and
increased lipid accumulation (33). An indirect mechanism of this
effect may be through the DEX-mediated induction of C/EPBδ, as
was recently demonstrated by Armengol et al. (32). Taken together,
these results demonstrate that Pref-1 plays an important role in the
regulation of both WAT and BAT differentiation.
Dexamethasone suppresses Pref-1 expression in preadipocytes
allowing for the eventual induction in PPARγ expression and
differentiation of preadipocytes into adipocytes. Though the
adipocyte differentiation process has been well studied, little is
known about the transition steps from embryonic stem cells (ESC)
or mesenchymal stem cells (MSC) to preadipocytes (34). A poten-
tial role of Pref-1 in the commitment stage of adipogenesis has
been revealed via the use of MSCs. These pluripotent MSCs can
differentiate into adipocytes upon treatment with IBMX and DEX.
It has recently been reported that IBMX increases Pref-1 expres-
sion initially (35), followed by a DEX-mediated decrease in Pref-1
expression, showing a transient rise in the Pref-1 level in MSCs
at the commitment stage prior to adipocyte differentiation. Simi-
larly, during differentiation of human fetal MSCs into adipocytes,
the Pref-1 expression level rose early in the differentiation process
but decreased in the later stages. Furthermore, epinephrine treat-
ment in mouse ESC was reported to induce Pref-1 expression and
cell proliferation. Interestingly, the Pref-1 level was increased at
the commitment stage, indicating that epinephrine may induce
cells to become committed to the adipocyte lineage. This effect
could be reversed by treatment with antagonists of the Neuropep-
tide Y (NPY) receptor (36). These observations together suggest
that commitment to the adipocyte lineage involves Pref-1 induc-
tion (37), and Pref-1 may be used as a marker for precursors of
adipogenesis.
The identity of adipose precursors remains an active area of
research. Lineage tracing has often been used to understand the
developmental origin of various cell types (38–40). By using the
PPARγ locus, Tang et al. (41) first showed that adipose progen-
itors express PPARγ, and they reside near the vasculature. How-
ever, PPARγ is expressed not only in preadipocytes but also in
differentiated adipocytes, which makes it tricky to discern adi-
pose precursors. Regardless, other recent reports also indicate that
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FIGURE 1 | Pref-1 inhibition of adipogenesis. Membrane bound
Pref-1 is cleaved by TACE to generate a 50 kDa soluble factor. Pref-1
interacts with fibronectin and via integrin α5β1 activates MEK/ERK,
which increases Sox9, which then binds to the promoter regions of
C/EBP β/δ to block adipocyte differentiation. Dexamethasone has
been shown to decrease Pref-1 expression while IBMX, epinephrine,
growth hormone and estrogen have been shown to increase Pref-1
expression.
adipocytes may come from endothelial cells or pericytes (8, 42,
43). Adipocyte precursor cells were also identified in the adipose
stroma using a combination of fluorescence-activated cell sorting.
These cells were found to have a unique cell surface signature,
including the presence of CD34, Sca-1, and CD24 (44). And, we
recently employed Pref-1 labeling to identify and characterize adi-
pose precursors throughout development, as well as during diet
induced expansion of WAT (Hudak and Sul, unpublished results).
In humans, Pref-1 has been recently shown to be clinically
relevant and is associated with extreme early onset obesity. In
trio studies of obese children and their biological parents, the
association of Pref-1 with obesity became apparent only when
considering imprinting of the gene, and supported the existence of
polar overdominance in humans (45). Furthermore, in comparing
Pref-1 expression levels in metabolically healthy obese (MHO) and
metabolically unhealthy obese (MUO) individuals, MHO patients
had lower levels of Pref-1 in their adipose tissue (46). These
results indicated that metabolically healthy patients have increased
preadipocyte differentiation which was also associated with a
more favorable inflammatory profile. Therefore, MHO patients
may have an increased number of smaller adipocytes, rather than
increased adipocyte size, implying that increased adipocyte size
may be an important process underlying metabolic disease in
obesity.
REGULATION OF PREF-1 EXPRESSION DURING
ADIPOGENESIS
Pref-1 is part of the imprinted gene cluster, Pref-1-Dio3 (47, 48).
Ten imprinted genes have been identified in this cluster. There
are three paternally expressed genes, Pref-1, Paternally Expressed
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Gene 11 [Peg11, also called Retrotransposon-like 1(Rtl1)] and type
3 deiodinase (Dio3), and seven maternally expressed genes coding
for non-coding RNAs (48, 49). Interestingly, Pref-1 is located in
the same imprinted region as Dio3 (50), an inhibitor of T3, and
changes in Dio3 expression levels during differentiation parallel
that of Pref-1. Thyroid hormone is critical for BAT function and
thermogenesis (51, 52), and T3 can stimulate brown adipocyte
differentiation (53). Accordingly, DEX can suppress expression of
both Dio3 and Pref-1 in cultured preadipocytes. In this regard,
high levels of Dio3 have been detected in differentiating pri-
mary brown preadipocytes. Together, the coordinated expression
of Pref-1 and Dio3 further implicate the important role they may
play during brown adipocyte differentiation (54). Not only is DNA
methylation important in the regulation of Pref-1 expression, but
modification of histones also plays a role in expression of these
imprinted genes. With regard to Pref-1 repression during adipo-
genesis, a recent study revealed that a decreased level of H3 K4
tri-methylation (55) leads to de-repression of Pref-1, and the Pref-
1 locus exhibits lower levels of active chromatin makers, such as
H3 K4 tri-methylation as well as H3 and H4 acetylation in 10T1/2
cells compared to committed 3T3-L1 preadipocytes. Furthermore,
the Pref-1 gene showed a predominant enrichment of H3 K27 tri-
methylation, demonstrating that these repressive marks play a role
in silencing Pref-1 gene expression in 10T1/2 cells (56, 57).
Regulation of adipogenesis by certain growth factors has been
reported to be through modulating Pref-1 levels. Thus, growth
hormone has been previously reported to maintain high levels of
Pref-1 in 3T3-L1 cells to prevent differentiation of preadipocytes
(58, 59). Furthermore, growth hormone stimulates production of
Insulin-like growth factor-1 (IGF-1), which is reduced by Pref-1
treatment, showing the ability of Pref-1 to regulate growth hor-
mone levels (60). It has also been suggested that IGF-1 may be able
to bypass the inhibition of Pref-1 on adipocyte differentiation of
3T3-L1 cells (61). Interestingly, in human patients with anorexia
nervosa, there was an increased level of Pref-1, which correlated
to an increased number of undifferentiated cells with a corre-
sponding decrease in BAT mass (62). Furthermore, these patients
have low gonadal steroids and treating adolescent female anorexia
nervosa with estradiol caused a significant decrease in Pref-1 lev-
els (63). In postmenopausal women, estrogen deficiency leads to
increased serum levels of Pref-1, which is associated with bone
loss, and could be normalized with estrogen replacement therapy
(64). Overall, there seems to be evidence of estrogen regulation of
Pref-1 expression, which plays a role in regulating homeostasis of
adipocyte as well as osteocyte abundance.
CONCLUSION
Obesity is characterized by increased adipose tissue through both
hypertrophy and hyperplasia, and much interest has been garnered
to understand the regulation of this process. In this regard, Pref-1
has been used as a preadipocyte marker, and is notable in its abil-
ity to prevent adipocyte differentiation in an autocrine/paracrine
manner. Pref-1 interacts with fibronectin and activates MEK/ERK
to induce Sox9 expression, which blocks adipocyte differentiation
by binding to the promoter regions of C/EBPβ and C/EBPδ and
preventing activation of C/EBPα and PPARγ. Several hormones
and other cytokines have been suggested to either regulate or be
regulated by Pref-1, further suggesting the critical role of Pref-1 in
the maintenance of the preadipocyte state. Pref-1 expression tran-
siently increases early during differentiation of MSCs. Pref-1 may
be a valuable tool as a marker of precursor cells and we are employ-
ing Pref-1 to label adipose precursors for lineage tracing and inves-
tigation of adipose tissue development. Additionally, given that
imprinted genes function in fetal development and growth and
with its effects on chondrogenesis and osteogenesis, Pref-1 most
likely functions beyond the control of adipogenesis and mesenchy-
mal cell fate. Furthermore, Pref-1 is associated with early onset
obesity in humans. Uncovering the Pref-1-fibronectin interaction
has begun to shed light on the molecular mechanism underlying
the function of Pref-1 and Pref-1 signaling in adipogenesis.
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